Skip to main content
. 1999 Dec;48(6):819–825. doi: 10.1046/j.1365-2125.1999.00097.x

Figure 4.

Figure 4

a) Plasma glucose concentration-time course (mean±s.d.) during the respective treatments A (thioctic acid, •), B (glibenclamide, ○), C (TA+glibenclamide, ▪) and D (TA+acarbose, ▵). It should be noted that a number of volunteers needed extra glucose >2 h after glibenclamide dosing (see Methods). b) Plasma insulin concentration-time course (mean±s.d.) during the respective treatments A (thioctic acid, •), B (glibenclamide, ○), C (TA+glibenclamide, ▪) and D (TA+acarbose, ▵), — baseline.